Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (421-430 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2007
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysisKen Herrmann, Katja Ott, Andreas K Buck, et al.
European Urology|December 27, 2011
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomyTobias Maurer, Michael Souvatzoglou, Hubert Kübler, et al.
EJNMMI Physics|June 15, 2026
Limitations in diagnostics and quantification of small lesions with low uptake in the clinical context of prostate <sup>18</sup>F/<sup>68</sup>Ga-PSMA PET/MRIMaike E Lindemann, Walter Jentzen, Alina Küper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolismStephan Metz, Carl Ganter, Sylvie Lorenzen, et al.
Nuklearmedizin. Nuclear Medicine|March 17, 2022
Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective StudyAndrea Farolfi, Nader Hirmas, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2022
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?René Hosch, Manuel Weber, Miriam Sraieb, et al.
European Radiology|June 20, 2023
[<sup>18</sup>F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?Kai Jannusch, Janna Morawitz, Bernd Schweiger, et al.
Cancer|December 13, 2012
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcomaAkram Al-Ibraheem, Andreas K Buck, Matthias R Benz, et al.
European Radiology|December 1, 2023
Recurrent prostate cancer: combined role for MRI and PSMA-PET in <sup>68</sup>Ga-PSMA-11 PET/MRIKai Jannusch, Nils Martin Bruckmann, Janna Morawitz, et al.
Pageof 73

Showing results (421-430 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2007
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysisKen Herrmann, Katja Ott, Andreas K Buck, et al.
European Urology|December 27, 2011
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomyTobias Maurer, Michael Souvatzoglou, Hubert Kübler, et al.
EJNMMI Physics|June 15, 2026
Limitations in diagnostics and quantification of small lesions with low uptake in the clinical context of prostate <sup>18</sup>F/<sup>68</sup>Ga-PSMA PET/MRIMaike E Lindemann, Walter Jentzen, Alina Küper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolismStephan Metz, Carl Ganter, Sylvie Lorenzen, et al.
Nuklearmedizin. Nuclear Medicine|March 17, 2022
Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective StudyAndrea Farolfi, Nader Hirmas, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2022
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?René Hosch, Manuel Weber, Miriam Sraieb, et al.
European Radiology|June 20, 2023
[<sup>18</sup>F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?Kai Jannusch, Janna Morawitz, Bernd Schweiger, et al.
Cancer|December 13, 2012
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcomaAkram Al-Ibraheem, Andreas K Buck, Matthias R Benz, et al.
European Radiology|December 1, 2023
Recurrent prostate cancer: combined role for MRI and PSMA-PET in <sup>68</sup>Ga-PSMA-11 PET/MRIKai Jannusch, Nils Martin Bruckmann, Janna Morawitz, et al.
Pageof 73